These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2902813)

  • 1. [Benzodiazepine antagonism by RO 15-1788: psychometric, hormonal and biophysical parameters].
    Noderer J; Duka T; Dorow R
    Anaesthesist; 1988 Aug; 37(8):535-42. PubMed ID: 2902813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in noradrenaline plasma levels and behavioural responses induced by benzodiazepine agonists with the benzodiazepine antagonist Ro 15-1788.
    Duka T; Ackenheil M; Noderer J; Doenicke A; Dorow R
    Psychopharmacology (Berl); 1986; 90(3):351-7. PubMed ID: 2878461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study.
    Gerra G; Zaimovic A; Giusti F; Moi G; Brewer C
    Addict Biol; 2002 Oct; 7(4):385-95. PubMed ID: 14578014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous flumazenil following prolonged exposure to lormetazepam in humans: lack of precipitated withdrawal.
    Gerra G; Giucasto G; Zaimovic A; Fertonani G; Chittolini B; Avanzini P; Caccavari R; Delsignore R
    Int Clin Psychopharmacol; 1996 Jun; 11(2):81-8. PubMed ID: 8803645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency?
    Kiefer F; Horntrich M; Jahn H; Wiedemann K
    Psychopharmacology (Berl); 2002 Aug; 162(4):433-7. PubMed ID: 12172698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P; Touchon J; Billardon M
    Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous flumazenil following acute and repeated exposure to lorazepam in healthy volunteers: antagonism and precipitated withdrawal.
    Griffiths RR; Evans SM; Guarino JJ; Roache JD; Furman WR; Liebson I; Schwam EM
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1163-74. PubMed ID: 8510001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DHEAS and POMS measures identify cocaine dependence treatment outcome.
    Wilkins JN; Majewska MD; Van Gorp W; Li SH; Hinken C; Plotkin D; Setoda D
    Psychoneuroendocrinology; 2005 Jan; 30(1):18-28. PubMed ID: 15358439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [alpha-beta L-aspartate magnesium in treatment of chronic benzodiazepine abuse: controlled and double-blind study versus placebo].
    Hantouche EG; Guelfi JD; Comet D
    Encephale; 1998; 24(5):469-79. PubMed ID: 9850822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antagonism of the effects of benzodiazepines using flumazenil (Ro 15-1788)].
    Lauven PM; Kulka P
    Anasth Intensivther Notfallmed; 1988 Jun; 23(3):153-8. PubMed ID: 2899985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The action of the benzodiazepine antagonist Ro 15-1788].
    Doenicke A; Suttmann H; Kapp W; Kugler J; Ebentheuer H
    Anaesthesist; 1984 Aug; 33(8):343-7. PubMed ID: 6148904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing and side effects of flumazenil for dental outpatients receiving intravenous sedation with midazolam.
    Misaki T; Kyoda N; Oka S; Takada K; Kunimatu T; Tajima A
    Anesth Prog; 1997; 44(4):127-31. PubMed ID: 9481956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzodiazepine antagonist Ro 15-1788 in self-poisoning. Diagnostic and therapeutic use.
    Hofer P; Scollo-Lavizzari G
    Arch Intern Med; 1985 Apr; 145(4):663-4. PubMed ID: 2859006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical dependence in baboons chronically treated with low and high doses of diazepam.
    Kaminski BJ; Sannerud CA; Weerts EM; Lamb RJ; Griffiths RR
    Behav Pharmacol; 2003 Jul; 14(4):331-42. PubMed ID: 12838039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin regulation of the human stress response.
    Hood SD; Hince DA; Robinson H; Cirillo M; Christmas D; Kaye JM
    Psychoneuroendocrinology; 2006 Oct; 31(9):1087-97. PubMed ID: 16962720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flunitrazepam and lormetazepam do not affect the pharmacokinetics of the benzodiazepine antagonist Ro 15-1788.
    Klotz U; Duka T; Dorow R; Doenicke A
    Br J Clin Pharmacol; 1985 Jan; 19(1):95-8. PubMed ID: 3919752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the central effects of a new partial benzodiazepine agonist Ro 16-6028 in man: pharmaco-EEG and psychometric studies.
    Saletu B; Grünberger J; Linzmayer L
    Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):51-65. PubMed ID: 2921096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human studies on the benzodiazepine receptor antagonist beta-carboline ZK 93 426: antagonism of lormetazepam's psychotropic effects.
    Duka T; Goerke D; Dorow R; Höller L; Fichte K
    Psychopharmacology (Berl); 1988; 95(4):463-71. PubMed ID: 2905500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early clinical pharmacological trials with a novel partial benzodiazepine agonist/antagonist Ro 17-1812 using pharmaco-EEG and psychometry.
    Saletu B; Grünberger J; Linzmayer L
    Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):373-89. PubMed ID: 3736281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of the benzodiazepine antagonist Ro 15-1788 following anesthesia induced by flunitrazepam].
    Lauven PM; Ebeling BJ; Stoeckel H; Dierke-Dzierzon C
    Anasth Intensivther Notfallmed; 1986 Dec; 21(6):311-4. PubMed ID: 3101535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.